These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15225662)
21. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy. Altenburg J; de Graaff CS; van der Werf TS; Boersma WG Respiration; 2011; 81(1):75-87. PubMed ID: 20733282 [TBL] [Abstract][Full Text] [Related]
22. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Weber FH; Richards RD; McCallum RW Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625 [TBL] [Abstract][Full Text] [Related]
23. Special drug communication teleconference. August 7, 1992. Ear Nose Throat J; 1992 Sep; 71(9):383-4, 387-90. PubMed ID: 1425376 [No Abstract] [Full Text] [Related]
24. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254 [TBL] [Abstract][Full Text] [Related]
25. [The safety of macrolide antibiotics: critical analysis]. Sinopal'nikov AI; Andreeva IV; Stetsiuk OU Klin Med (Mosk); 2012; 90(3):23-30. PubMed ID: 22690560 [TBL] [Abstract][Full Text] [Related]
26. Effects of macrolide antibiotics on rat embryonic heart function in vitro. Nilsson MF; Webster WS Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):189-98. PubMed ID: 24753334 [TBL] [Abstract][Full Text] [Related]
28. Role of prokinetic drugs for treatment of postoperative ileus in the horse. Dart AJ; Hodgson DR Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763 [TBL] [Abstract][Full Text] [Related]
29. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
30. Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats. Karmakar S; Padman A; Swamy Mane N; Sen T Eur J Pharmacol; 2013 Jun; 709(1-3):80-4. PubMed ID: 23567068 [TBL] [Abstract][Full Text] [Related]
32. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases. Eraković Haber V; Bosnar M; Kragol G Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894 [TBL] [Abstract][Full Text] [Related]
35. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval]. Calderone V; Cavero I Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149 [TBL] [Abstract][Full Text] [Related]
38. Comment: the new macrolide antibiotics and terfenadine. Cortese LM; Bjornson DC Ann Pharmacother; 1992; 26(7-8):1019. PubMed ID: 1504390 [No Abstract] [Full Text] [Related]
39. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. Corrao G; Botteri E; Bagnardi V; Zambon A; Carobbio A; Falcone C; Leoni O Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):31-40. PubMed ID: 15390219 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antibacterial activity of novel bifunctional macrolides. Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]